A novel point mutation of the splicing donor site in the intron 2 of the plasmin inhibitor gene

Thrombosis and Haemostasis

Volumn 84, Issue 2, 2000, Pages 307-311

  Yoshinaga, Haruhiko ^a   Hirosawa, Shinsaku ^a   Chung, Dong Hui ^a   Miyasaka, Nobuyuki ^a   Aoki, Nobuo ^a   Favier, Remi ^b  

^a TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

^b ARMAND TROUSSEAU HOSPITAL   (France)

Author keywords

Fibrinolysis; Mutation; Plasmin inhibitor; Splicing donor site

Indexed keywords

ANTIPLASMIN; MESSENGER RNA;

ARTICLE; CASE REPORT; GENETIC TRANSCRIPTION; GENETIC TRANSFECTION; HUMAN; INTRON; MALE; POINT MUTATION; PRIORITY JOURNAL; RNA SPLICING; STOP CODON;

EID: 0033858006     PISSN: 03406245     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-0037-1614012     Document Type: Article

References (33)

1. 2-plasmin inhibitor from human plasma. A novel proteinase inhibitor which inhibits activator-induced clot lysis. J Biol Chem 1976; 251: 5956-65.
2. 2-plasmin inhibitor in fibrinolytic states. J Clin Invest 1977; 60: 361-9.
3. Aoki N, Harpel PC. Inhibitors of the fibrinolytic enzyme system. Semin Thromb Hemost 1984; 10: 24-41.
4. Wiman B, Collen D. On the kinetics of the reaction between human anti-plasmin and plasmin. Eur J Biochem 1978; 84: 573-8.
5. 2-macroglobulin. Thromb Haemost 1978; 39: 22-31.
6. 2-plasmin inhibitor to fibrin by fibrin-stabilizing factor. J Clin Invest 1980; 65: 290-7.
7. 2-plasmin inhibitor to fibrin in inhibition of fibrinolysis and in hemostasis. J Clin Invest 1982; 69: 536-42.
8. Jansen JW, Haverkate F, Koopman J, Nieuwenhuis HK, Kluft C, Boschman TA. Influence of factor XIIIa activity on human whole blood clot lysis in vitro. Thromb Haemost 1987; 57: 171-5.
9. 2-plasmin inhibitor in human plasma. Biochem J 1993; 291: 623-5.
10. 2-plasmin inhibitor from human plasma and culture media of Hep G2 cells. Biochem Biophys Res Commun 1994; 200: 417-22.
11. 2-plasmin inhibitor. J Biochem 1989; 106: 703-7.
12. 2-plasmin inhibitor gene. Proc Natl Acad Sci USA 1988; 85: 6836-40.
13. 2-plasmin inhibitor gene (PLI) to 17p13. Cytogenet Cell Genet 1993; 62: 190-1.
14. 2-plasmin inhibitor associated with severe hemorrhagic tendency. J Clin Invest 1979; 63: 877-84.
15. 2-plasmin inhibitor. Blood 1980; 55: 483-8.
16. 2-plasmin inhibitor and its deficiency states. J Lab Clin Med 1988; 112: 671-8.
17. Aoki N. Hemostasis associated with abnormalities of fibrinolysis. Blood Rev 1989; 3: 11-7.
18. 2-antiplasmin molecule associated with an autosomal recessive hemorrhagic disorder. J Clin Invest 1987; 80: 1391-400.
19. 2-antiplasmin Enschede: alanine insertion and abolition of plasmin inhibitory activity. Science 1987; 238: 209-11.
20. 2-plasmin inhibitor. A frameshift mutation leading to elongation of the deduced amino acid sequence. J Clin Invest 1989; 83: 1598-604.
21. 2-PI-Okinawa). Deletion of Glu137 by a trinucleotide deletion blocks intracellular transport. J Biol Chem 1989; 264: 18213-9.
22. 2-plasmin inhibitor. Blood 1990; 75: 1092-6.
23. 2-plasmin inhibitor is impaired by amino acid deletion in a small region of the molecule. J Biochem (Tokyo) 1994; 115: 293-7.
24. 2 antiplasmin deficiency in a child. Anesth Analg 1997; 84: 1147-9.
25. 2-plasmin inhibitor deficiency. Pediatr Radiol 1998; 28: 978-80.
26. Giannelli F, Green PM, Sommer SS, Poon M, Ludwig M, Schwaab R, Reitsma PH, Goossens M, Yoshioka A, Figueiredo MS, Brownlee GG. Haemophilia B: database of point mutations and short additions and deletions - eighth edition. Nucleic Acids Res 1998; 26: 265-8.
27. Reitsma PH, Poort SR, Bernardi F, Gandrille S, Long GL, Sala N, Cooper DN. Protein C deficiency: a database of mutations. For the Protein C & S Subcommittee of the Scientific and Standardization Committee of the International Society on Thrombosis and Haemostasis. Thromb Haemost 1993; 69: 77-84.
28. Krawezak M, Reiss J, Cooper DN. The mutational spectrum of single base-pair substitutions in mRNA splice junctions of human genes: causes and consequences. Hum Genet 1992; 90: 41-54.
29. 0-thalassemic gene causes abnormal RNA splicing. Cell 1982; 29: 903-11.
30. Berg LP, Grundy CB, Thomas F, Millar DS, Green PJ, Slomski R, Reiss J, Kakkar W, Cooper DN. De novo splice site mutation in the antithrombin III (AT3) gene causing recurrent venous thrombosis: demonstration of exon skipping by ectopic transcript analysis. Genomics 1992; 13: 1359-61.
31. Shapiro MB, Senapathy P. RNA splice junctions of different classes of eukaryotes: sequence statistics and functional implications in gene expression. Nucleic Acids Res 1987; 15: 7155-74.
32. Robberson BL, Cote GJ, Berget SM. Exon definition may facilitate splice site selection in RNAs with multiple exons. Mol Cell Biol 1990; 10: 84-94.
33. 2-plasmin inhibitor for degradation by the proteasome. J Biol Chem 2000; 275: 4981-7.